ClinicalTrials.govpublic full text
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
alzheimer disease, interleukin, neuroinflammation, regulatory t cells, microglia, synaptic density, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843618
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.